Panagopoulos P, Maltezos E, Hatzakis A, & Paraskevis D. (2017). Hyperbilirubinemia in atazanavir treated HIV-infected patients: The impact of the UGT1A1*28 allele. Dove Medical Press.
Chicago Style (17th ed.) CitationPanagopoulos P, Maltezos E, Hatzakis A, and Paraskevis D. Hyperbilirubinemia in Atazanavir Treated HIV-infected Patients: The Impact of the UGT1A1*28 Allele. Dove Medical Press, 2017.
MLA (9th ed.) CitationPanagopoulos P, et al. Hyperbilirubinemia in Atazanavir Treated HIV-infected Patients: The Impact of the UGT1A1*28 Allele. Dove Medical Press, 2017.
Warning: These citations may not always be 100% accurate.